New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

News

Stay informed with the latest developments, research breakthroughs, and stories in the world of rare kidney diseases. We are dedicated to providing up-to-date information and updates on our initiatives, events, and the ongoing battle against RKD. Whether you are a patient, caregiver, healthcare professional, or supporter, our goal is to keep you connected with the latest advancements and resources available in the fight against these challenging conditions.

News

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

News

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

News

NephCure Celebrates C3G Awareness Day on September 25, 2026

News

NephCure Specialist of the Month: Dr. Rupali Avasare

News

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

News

NephCure Specialist of the Month: Dr. Fahad Aziz

News

NephCure Celebrates Inaugural Membranous Nephropathy Awareness Day on August 11, 2026  

News

NephCure Specialist of the Month: Meet Dr. Kirk Campbell

News

The FDA Grants Accelerated Approval to Atacicept for Adults with IgAN

News

NephCure Celebrates FSGS Awareness Day on June 9th, 2026 

News

From Patient to Advocate: My First Rare Kidneys on the Hill Day

News

NephCure Celebrates IgA Nephropathy (IgAN) Awareness Day on May 14, 2026

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.